This is a £2M Award (subject to final negotiations) that will allow the Reyes Group to move a step closer to the final stages of the clinical trials for their P. vivax vaccine.
The DPFS (Developmental Pathway Funding Scheme) is a key part of MRC’s Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including "repurposing" of existing therapies.